Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
4 min read
Chia Tai Tianqing Pharmaceutical initiates global multicenter phase III clinical trials for the pan-PPAR agonist Lanifibranor
13 September 2023
On Sept 11, 2023, Chia Tai Tianqing Pharmaceutical launched a global phase III trial, evaluating Lanifibranor's efficacy and safety in adult NASH patients with stage 2/3 hepatic fibrosis, excluding cirrhosis.
Drug Insights
4 min read
Pharmaceutical Insights: Exemestane's R&D Progress and its Mechanism of Action on Drug Target
13 September 2023
This article summarized the latest R&D progress of Exemestane, the Mechanism of Action for Exemestane, and the drug target R&D trends for Exemestane.
Valuable Targets
5 min read
Understanding the Development Progress of JAK2 Inhibitor
13 September 2023
JAK2 (Janus kinase 2) is an enzyme that plays a crucial role in the human body, particularly in the regulation of cell growth and differentiation.
Drug Insights
4 min read
Exploring Etomidate's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
13 September 2023
This article summarized the latest R&D progress of Etomidate, the Mechanism of Action for Etomidate, and the drug target R&D trends for Etomidate.
Latest Hotspot
3 min read
Abbisko Therapeutics' CSF-1R Inhibitor, Pimicotinib, Approved for Global Multicenter Phase 3 Clinical Trials in Europe
13 September 2023
On September 11, 2023, Abbisko Therapeutics announced that its innovative CSF-1R inhibitor pimicotinib (ABSK021) was approved by the European Medicines Agency.
Drug Insights
4 min read
Decoding Droperidol: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
13 September 2023
This article summarized the latest R&D progress of Droperidol, the Mechanism of Action for Droperidol, and the drug target R&D trends for Droperidol.
Bio Sequence
2 min read
Ways to Evaluate the Worldwide R&D Progress of Our Study Sequence
13 September 2023
The progress of R&D efforts in a life-science area of study can greatly affect the likelihood of breakthroughs and advancements. So, how do we analyze the global research and development progress of the sequence we are studying? I recommend that you use the Patsnap Bio Sequence Database to query data and information.
Drug Insights
4 min read
Deep Scientific Insights on Dofetilide's R&D Progress
13 September 2023
This article summarized the latest R&D progress of Dofetilide, the Mechanism of Action for Dofetilide, and the drug target R&D trends for Dofetilide.
Latest Hotspot
3 min read
Phanes Therapeutics reports its first patient has been administered with PT217 in a Phase 1 trial
13 September 2023
Biotech firm, Phanes Therapeutics, has announced its Phase 1 clinical trial of PT217, a first-in-class drug targeting DLL3 and CD47 in small cell lung cancer. The trial uses a new IgG-like bispecific antibody and the first patient has been treated.
Drug Insights
4 min read
An In-depth Analysis of Divalproex sodium's R&D Progress
13 September 2023
This article summarized the latest R&D progress of Divalproex sodium, the Mechanism of Action for Divalproex sodium, and the drug target R&D trends for Divalproex sodium.
Bio Sequence
2 min read
Searching for Modified Sequences: The Best Biological Databases to Consider
13 September 2023
Sequence modification is an important attribute of a sequence, particularly in the field of small nucleic acids. Sequence modifications, including fluorescence labeling, glycosylation, phosphorylation, and others, can enhance the functionality of a sequence, making them highly meaningful. In the Patsnap Bio Sequence Database, you can search for modified sequences.
Drug Insights
4 min read
Desonide: Detailed Review of its Transformative R&D Success, Mechanism of Action
13 September 2023
This article summarized the latest R&D progress of Desonide, the Mechanism of Action for Desonide, and the drug target R&D trends for Desonide.